Page 4 - Nxc 201 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nxc 201. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nxc 201 Today - Breaking & Trending Today

Immix Biopharma Subsidiary Nexcella Completes Pre-IND

Published: June 26, 2023

LOS ANGELES, June 26, 2023 (GLOBE NEWSWIRE) -- Nexcella, Inc., a subsidiary of Immix Biopharma, Inc. (“Nexcella”, “Company”, “We” or “Us”), a...

Source: globenewswire.com

Related Topics:

Ilya RachmanGabriel MorrisAlex LoboLos AngelesImmix Biopharma IncNexcella IncInternational Myeloma Working GroupExchange CommissionImmix BiopharmaPre Investigational New DrugChief Executive OfficerChief Financial OfficerMultiple MyelomaUniform Response CriteriaTissue Specific TherapeuticsOrphan Drug DesignationRare Pediatric Disease DesignationRisk FactorAnnual ReportNasdaq ImmxImmix BiopharmaNxc 201